RhIL-11
Jump to navigation
Jump to search
| RhIL-11 | |
|---|---|
| Term | RhIL-11 |
| Short definition | rhIL-11 - A drug used to increase the number of blood cells, particularly platelets, in some cancer patients receiving chemotherapy. rhIL-11 is a form of interleukin-11 (a cytokine normally made by supporting cells in the bone marrow) that is made in the laboratory. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
rhIL-11 - A drug used to increase the number of blood cells, particularly platelets, in some cancer patients receiving chemotherapy. rhIL-11 is a form of interleukin-11 (a cytokine normally made by supporting cells in the bone marrow) that is made in the laboratory. It's a kind of biological response modifier. Also called Neumega, Oprelvekin and recombinant human interleukin-11
External links
- Medical encyclopedia article on RhIL-11
- Wikipedia's article - RhIL-11
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski